Is a complete APUS research report available?

No complete published report is available for Apimeds Pharmaceuticals US, Inc. (APUS) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Apimeds Pharmaceuticals US, Inc. (APUS)

NYSEAMERICAN: APUS · USD

$5.75

-2.25 (-28.1%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first APUS analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	8.7M
Shares out	1.5M
Volume	252,849

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Market cap: 8.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

All APUS indicators

Market & fundamental data

Available fields

124

Groups with data

Currency

USD

Showing 124 of 124 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001894525
Company name	Apimeds Pharmaceuticals US, Inc.
Country	United States
Country code	US
Cusip	03771D201
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
Industry PE	90.42
Industry PE Fwd	14.46
IPO Date	2025-05-09
Isin	US03771D2018
Last refreshed	2026-07-30
Market cap	$8.7M
Market cap category	Nano-Cap
Price	$5.75
Price currency	USD
Sector	Healthcare
Sector PE	45.63
Sector PE Fwd	24.38
Sic	2834
Symbol	APUS
Website	https://www.mindwavedao.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
FCF yield	-64.4%

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income Growth Years	0%
ROIC	-78.61

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Current Assets	$9.1M
Current Liabilities	$1.1M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-29.09%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	10.31
All Time High	59.7
All Time High Change	-90.37%
All Time High Date	2026-05-05
All Time Low	5.08
All Time Low Change	13.19%
All Time Low Date	2026-07-29
ATR	1.55
Beta1y	0.03
Ch YTD	-64.94
High	8.28
High52	59.7
High52 Date	2026-05-05
High52ch	-90.37%
Low	5.08
Low52	5.08
Low52 Date	2026-07-29
Low52ch	13.19%
Ma50ch	-44.22%
Premarket Change Percent	-2.38
Premarket Price	$7.81
RSI	36.9
RSI Monthly	0
RSI Weekly	31.85
Sharpe ratio	-0.69x
Sortino ratio	-0.97
Total Return	-29.09%
Tr YTD	-64.94
Tr1m	-36.11%
Tr1w	-12.88%
Tr3m	-69.41%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	725,942%
Float Percent	48.1%
Net Borrowing	250,100
Shares Insiders	9.38%
Shares Institutions	2.97%
Shares Out	1,509,118
Shares Qo Q	21.28%
Shares Yo Y	29.09%
Short Float	2.42%
Short Ratio	0.99
Short Shares	1.16

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-7.2M
Adjusted OCF	-7,141,918
Average Volume	30,054.45x
CAPEX	$-35,909
Ch1m	-36.11
Ch1w	-12.88
Ch3m	-69.41
Ch6m	-70.66
Change	-28.13%
Change From Open	-29.01
Close	8
Days Gap	1.25
Depreciation Amortization	1,721
Dollar Volume	1,453,881.8
Earnings Date	2026-08-18
Earnings Time	amc
EBIT	$-21.1M
EBITDA	$-21.1M
F Score	0
FCF	$-5.2M
FCF Per Share	$-3.47
Financing CF	12,203,146
Fiscal Year End	December
Founded	2,020
Investing CF	-35,909
Ipr	34.88
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-26
Last Report Date	2025-09-30
Last Split Date	2026-07-24
Last Split Type	Reverse
Last10k Filing Date	2026-05-04
Ma20	7.12
Ma20ch	-19.22%
Net CF	6,960,046
Next Earnings Date	2026-08-18
Open	8.1
Optionable	No
Position In Range	20.94
Ppne	34,188
Pre Close	8
Price Date	2026-07-29
Relative Volume	8.41x
Share Based Comp	1,934,727
Tr6m	-70.66%
Us State	New Jersey
Views	173
Volume	252,849

Apimeds Pharmaceuticals US, Inc. (APUS)

Coverage state: Market snapshot only — no published research

Generate the first APUS analysis

Price

Financial snapshot

Fair-value bridge

Latest news · APUS

Valuation

Profitability

Trading

Next earnings

Sector percentile context

All APUS indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on APUS

Frequently asked questions